Search Results
Search for other papers by S A Khan in
Google Scholar
PubMed
Search for other papers by D Bhandare in
Google Scholar
PubMed
Search for other papers by R T Chatterton Jr in
Google Scholar
PubMed
Introduction The past decade has seen a proliferation of information regarding the endocrinology and intracrinology of the normal breast, and parallel information regarding the expression of hormone-related biomarker expression in
Cancer Epigenetics Group, School of Allied Health Sciences (ESTSP), Department of Pathology, Department of Epidemiology, Department of Urology, Department of Pathology and Molecular Immunology, Portuguese Oncology Institute, Research Center, Rua Dr António Bernardino Almeida, 4200-072 Porto, Portugal
Search for other papers by Filipa Quintela Vieira in
Google Scholar
PubMed
Search for other papers by Pedro Costa-Pinheiro in
Google Scholar
PubMed
Search for other papers by João Ramalho-Carvalho in
Google Scholar
PubMed
Search for other papers by Andreia Pereira in
Google Scholar
PubMed
Search for other papers by Francisco Duarte Menezes in
Google Scholar
PubMed
Search for other papers by Luís Antunes in
Google Scholar
PubMed
Cancer Epigenetics Group, School of Allied Health Sciences (ESTSP), Department of Pathology, Department of Epidemiology, Department of Urology, Department of Pathology and Molecular Immunology, Portuguese Oncology Institute, Research Center, Rua Dr António Bernardino Almeida, 4200-072 Porto, Portugal
Search for other papers by Isa Carneiro in
Google Scholar
PubMed
Search for other papers by Jorge Oliveira in
Google Scholar
PubMed
Cancer Epigenetics Group, School of Allied Health Sciences (ESTSP), Department of Pathology, Department of Epidemiology, Department of Urology, Department of Pathology and Molecular Immunology, Portuguese Oncology Institute, Research Center, Rua Dr António Bernardino Almeida, 4200-072 Porto, Portugal
Cancer Epigenetics Group, School of Allied Health Sciences (ESTSP), Department of Pathology, Department of Epidemiology, Department of Urology, Department of Pathology and Molecular Immunology, Portuguese Oncology Institute, Research Center, Rua Dr António Bernardino Almeida, 4200-072 Porto, Portugal
Search for other papers by Rui Henrique in
Google Scholar
PubMed
Cancer Epigenetics Group, School of Allied Health Sciences (ESTSP), Department of Pathology, Department of Epidemiology, Department of Urology, Department of Pathology and Molecular Immunology, Portuguese Oncology Institute, Research Center, Rua Dr António Bernardino Almeida, 4200-072 Porto, Portugal
Search for other papers by Carmen Jerónimo in
Google Scholar
PubMed
stages, PCa is frequently asymptomatic, fostering the use of biomarkers, such as serum prostate-specific antigen (PSA), for screening and identification of asymptomatic low-stage tumors, followed by prostate biopsy for diagnosis confirmation ( Stamey 1995
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
Search for other papers by Ignat Drozdov in
Google Scholar
PubMed
Search for other papers by Daniele Alaimo in
Google Scholar
PubMed
Search for other papers by Stephen Callahan in
Google Scholar
PubMed
Search for other papers by Nancy Teixiera in
Google Scholar
PubMed
Search for other papers by Lisa Bodei in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
establishment of therapeutic efficacy. Thus alternative approaches, radiological, nuclear medicine or co-value biomarker strategies are required to provide information of recurrent disease or therapeutic efficacy. Alternative or complementary evaluation methods
Search for other papers by Willemijn A van Gemert in
Google Scholar
PubMed
Search for other papers by Evelyn M Monninkhof in
Google Scholar
PubMed
Search for other papers by Anne M May in
Google Scholar
PubMed
Search for other papers by Sjoerd G Elias in
Google Scholar
PubMed
Department of Research methodology, Measurement and Data analysis, University of Twente, Enschede, the Netherlands
Search for other papers by Job van der Palen in
Google Scholar
PubMed
Search for other papers by Wouter Veldhuis in
Google Scholar
PubMed
Search for other papers by Maaike Stapper in
Google Scholar
PubMed
Search for other papers by Rebecca K Stellato in
Google Scholar
PubMed
Department of Health Sciences and EMGO Institute for Health and Care Research, VU University, Amsterdam, the Netherlands
Search for other papers by Jantine A Schuit in
Google Scholar
PubMed
MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, South Kensington Campus, London, UK
Search for other papers by Petra H Peeters in
Google Scholar
PubMed
Introduction Intervention studies suggest that body fat is an important mediator in the association between exercise and/or weight loss and biomarkers for risk of breast cancer in postmenopausalwomen. ( McTiernan et al. 2004 , McTiernan et
Search for other papers by Felicity E B May in
Google Scholar
PubMed
Search for other papers by Bruce R Westley in
Google Scholar
PubMed
predictive biomarker of response to endocrine therapy and to evaluate the response of breast cancer cells to TFF3. Materials and methods Cell culture Breast cancer cells were obtained from the American Type Culture Collection (Manassas, VA, USA
Department of Urology, Huizhou Municipal Central Hospital, Huizhou, Guangdong, China
Search for other papers by Yihao Chen in
Google Scholar
PubMed
Search for other papers by Jiahong Chen in
Google Scholar
PubMed
Search for other papers by Yongcheng Shi in
Google Scholar
PubMed
Search for other papers by Xiaohui Ling in
Google Scholar
PubMed
Search for other papers by Shumin Fang in
Google Scholar
PubMed
Search for other papers by Chuanfan Zhong in
Google Scholar
PubMed
Search for other papers by Fengping Liu in
Google Scholar
PubMed
Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangdong Key Laboratory of Urology, Guangzhou Institute of Urology, Guangzhou, Guangdong
Search for other papers by Weide Zhong in
Google Scholar
PubMed
Search for other papers by Xuecheng Bi in
Google Scholar
PubMed
Search for other papers by Zhong Dong in
Google Scholar
PubMed
Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China
Search for other papers by Jianming Lu in
Google Scholar
PubMed
, aside from tumor staging, there are no superior prognostic indicators ( Else et al. 2014 ). Given the limitations of staging-based prognosis, there is a pressing need to identify novel biomarkers for risk stratification of patients and the discovery of
School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, New South Wales, Australia
Search for other papers by Belinda van Zyl in
Google Scholar
PubMed
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales, Australia
Search for other papers by Denise Tang in
Google Scholar
PubMed
School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, New South Wales, Australia
Search for other papers by Nikola A Bowden in
Google Scholar
PubMed
, we review biomarkers of platinum chemotherapy resistance in ovarian cancer with a focus on biomarkers that are potentially targetable for future treatment combinations. Ovarian cancer subtypes There are 2 major subtypes of ovarian cancer that
Search for other papers by Yuriko Mori in
Google Scholar
PubMed
Search for other papers by Alexandru V Olaru in
Google Scholar
PubMed
Search for other papers by Yulan Cheng in
Google Scholar
PubMed
Search for other papers by Rachana Agarwal in
Google Scholar
PubMed
Search for other papers by Jian Yang in
Google Scholar
PubMed
Search for other papers by Delgermaa Luvsanjav in
Google Scholar
PubMed
Search for other papers by Wayne Yu in
Google Scholar
PubMed
Search for other papers by Florin M Selaru in
Google Scholar
PubMed
Search for other papers by Susan Hutfless in
Google Scholar
PubMed
Search for other papers by Mark Lazarev in
Google Scholar
PubMed
Search for other papers by John H Kwon in
Google Scholar
PubMed
Search for other papers by Steven R Brant in
Google Scholar
PubMed
Search for other papers by Michael R Marohn in
Google Scholar
PubMed
Search for other papers by David F Hutcheon in
Google Scholar
PubMed
Search for other papers by Mark D Duncan in
Google Scholar
PubMed
Search for other papers by Ajay Goel in
Google Scholar
PubMed
Division of Gastroenterology, Division of Gastroenterology, Division of Gastroenterology, Division of Gastroenterology, Section of Gastroenterology, Department of Surgery, Division of Gastroenterology, Department of Medicine
Division of Gastroenterology, Division of Gastroenterology, Division of Gastroenterology, Division of Gastroenterology, Section of Gastroenterology, Department of Surgery, Division of Gastroenterology, Department of Medicine
Search for other papers by Stephen J Meltzer in
Google Scholar
PubMed
, are not ideal for application to the asymptomatic population. Therefore, active investigations are now underway to discover noninvasive biomarkers, such as those found in stool, which could supplement or supplant colonoscopic screening
Search for other papers by Vincenzo Marotta in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Concetta Sciammarella in
Google Scholar
PubMed
Search for other papers by Maria Rosaria Ambrosio in
Google Scholar
PubMed
Search for other papers by Marta Bondanelli in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
-functional disease. This strikingly limits clinical utility of circulating CgA as diagnosis of functional and metastatic NENs is mainly obtained by specific biomarkers and imaging modalities or biopsy, respectively ( Jensen et al . 2012 , Pavel et al . 2012
Search for other papers by M Christine Bruce in
Google Scholar
PubMed
Search for other papers by Danielle McAllister in
Google Scholar
PubMed
Search for other papers by Leigh C Murphy in
Google Scholar
PubMed
estrogen receptors (ERs; Jensen et al . 1971 ). This heralded the beginning of an era of targeted therapies for breast cancer, identified the first biomarker used clinically to predict the biological behavior of breast cancer, and established the